Dr Paul Galvin

Funded Investigator

Dr Paul GALVIN was awarded his PhD in 1995 and joined the Tyndall National Institute (then NMRC), in 2000 where he now leads the Life Sciences Interface Group. Research within the Life Sciences Interface Group is focussed on exploiting the extensive design, fabrication and characterisation tools available in Tyndall, for applications related to health and environment.Within his role as leader of the Life Sciences Interface Group in Tyndall, he has facilitated the development of new collaborative research programmes in Tyndall through engagement with the leading medical device companies. Dr Galvin is a PI in the SFI INFANT centre for perinatal research, and a collaborator in the SFI BDI (Biomedical Diagnostics Institute) and INSIGHT (Big Data Analytics) centre. He initiated, wrote and coordinated a number of large international multidisciplinary research projects such as CF-CHIP (EC FP5 programme – €2.3 million) and SNiP2CHIP (EC FP6 programme – €3.2 million). He was one of the founding members of Nano2Life, the European Network of Excellence on Nanobiotechnology. In June 2011, he chaired the Organising Committee for the NanoBioEurope 2011 conference in Cork (Ireland), attended by delegates from 20 countries, and in September 2013 he chaired the Tyndall ICT for Health Industry Conference. To date, his research has been supported by EC FP5, 6 & 7 programmes in Health, NMP & ICT, and Irish funding agencies including SFI, Enterprise Ireland and the Higher Education Authority, withawarded grants for his research in excess of €4.5 million. He has served as an expert reviewer for several international funding agencies including EC FP5FP6 and FP7 programmes. He is currently vice chair for the NanoDiagnostics Working Group in the European Technology Platform for Nanomedicine. He has been a co-inventor on three filed patent applications, has over 60 international publications (see http://scholar.google.com/citations?sortby=pubdate&hl=en&user=THwp2roAAAAJ&view_op=list_works) and has presented his research at numerous international conferences around the world (including many invited papers and presentations) across a diversity of scientific disciplines.